HealthVerity vs Pfizer
Side-by-side comparison of AI visibility scores, market position, and capabilities
HealthVerity is a Philadelphia-based healthcare data management platform providing Identity, Privacy, Governance and Exchange (IPGE) infrastructure; raised $100M Series D in May 2025 led by Durable Capital;
About
HealthVerity is a Philadelphia-based healthcare technology company that operates the IPGE (Identity, Privacy, Governance and Exchange) platform — a unified infrastructure that enables more than 250 leading healthcare enterprises and more than 80% of top pharmaceutical companies to discover, access, and apply real-world healthcare data responsibly and at scale. The company's platform solves a fundamental challenge in healthcare data: combining data from disparate sources (claims, clinical records, pharmacy, lab, and specialty data) while preserving patient privacy and maintaining regulatory compliance.
Global biopharma with $63.6B FY2024 revenue; $43B Seagen ADC acquisition rebuilds post-COVID pipeline; patent cliff 2026-2028 for Eliquis; activist Starboard Value pushing restructuring.
About
Pfizer is one of the world's largest biopharmaceutical companies, founded in 1849 by cousins Charles Pfizer and Charles Erhart in Brooklyn, New York, and now headquartered in New York City. The company trades on NYSE (PFE) and reported $63.6 billion in total revenues for FY2024, normalizing from pandemic highs of $100 billion-plus in 2021-2022 driven by Comirnaty COVID-19 vaccine revenues with BioNTech and Paxlovid COVID antiviral sales. CEO Albert Bourla has led a strategic pivot to reset the company's long-term growth profile, anchored by the landmark $43 billion acquisition of Seagen in December 2023, adding a world-class antibody-drug conjugate (ADC) oncology pipeline including Padcev, Tukysa, Adcetris, and Tivdak.
AI Visibility Head-to-Head
Key Details
Also Compare
Track AI Visibility in Real Time
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.